Skew Flap vs Long Posterior Flap for Below Knee Amputation Early and Short- Term Outcomes (NCT06499506) | Clinical Trial Compass
CompletedNot Applicable
Skew Flap vs Long Posterior Flap for Below Knee Amputation Early and Short- Term Outcomes
Egypt40 participantsStarted 2024-07-01
Plain-language summary
Below knee amputations (BKAs) are frequently performed among vascular patients with end stage chronic limb threatening ischemia and / or complications of diabetes and diabetic foot infections and gangrene, It may also be necessary for patients with aggressive diabetic foot infections or gangrene, or both; for those with extensive venous ulceration; or following major trauma. and in the case of extremity sepsis.
There is two main methods for constructing the myocutaneous flaps in below knee amputation; the long posterior flap (LPF) and skew flap (SF).
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with chronic atherosclerotic occlusive disease of the lower extremity and threatening limb ischemia (intractable rest pain, ulcer or gangrene) for whom all other treatment options failed or inapplicable .
* patients with aggressive diabetic foot infections or gangrene, or both.
* Patients with extensive venous ulceration.
* Patients following major trauma with unsalvageable limb.
* Patients with nonfunctioning damaged limb as in Charcot joint disease.
* Patients with extensive limb sepsis.
Exclusion Criteria:
* Patients with local site infection not candidate for instant closure.
* Patients with bad general condition.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial compared two different surgical techniques — the skew flap and the long posterior flap — for below-knee amputation in people with diabetic foot or ischemic leg disease; which of these two approaches does my surgeon think would give me the best chance of wound healing based on my specific condition?
2Since this trial already completed and was measuring wound healing, re-amputation rates, and how quickly patients could get moving again, has my doctor seen the results, and what do those early findings suggest about which technique had better outcomes in people like me?
3If wound healing is one of the main things this trial was tracking, and I have diabetes or poor circulation, what signs of poor healing should I watch for after surgery and how would my care team handle a complication like re-amputation?
4This trial was not assigned a standard phase, which suggests it was comparing two existing surgical methods rather than testing a brand-new treatment — does that mean both flap techniques are already considered acceptable standard options, and if so, what guides my surgeon's choice between them?
5How soon after surgery were patients in this trial typically able to start mobilizing, and is that realistic for my situation given my overall health and any other conditions I have?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.